Oncology
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 1–12 of 62 articles
Quick answer
NovaPharmaNews Oncology hub for NMPA covers 62 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
PMDA approves ENHERTU for HER2-low breast cancer in Japan
ASCO26: Revolution's Daraxonrasib Phase III Data Reshapes Pancreatic Cancer Odds
Datroway Approved: A New Hope for Metastatic TNBC Patients
Kelun-Biotech Secures New Drug Approval for SKB118: Investor and BD Guide
China's Ascendancy in Oncology Research Alarms European Oncologists, Threatening Europe's Competitive Edge
ASCO 2026: Asian Oncology Innovation Takes Center Stage, Driving Global Clinical Trial Advancements
UK Clinical Trials in Oncology: Actions Driving Impact
Innovative Oncology Pharma Companies in China: A Look Ahead
Biomarkers and Digital Technologies Transforming Oncology in Asia
Clinical Trials Market in Oncology: Size and Growth Insights for 2034
Innovent Biologics and Pfizer: A $10.5B Oncology Partnership
Medical Advances Soar With APAC's Clinical Trial Growth in Oncology
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.